Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Deebiotech
Deyang (Guanghan City), Sichuan, China
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
Sichuan Deebiotech and its wholly owned subsidiary Sichuan Deebio Pharmaceutical commercially manufacture and export multiple bio‑enzyme and related APIs (e.g. kallidinogenase, pepsin, elastase, heparin sodium, cytochrome c, chondroitin sulfate, trypsin, chymotrypsin, ursodeoxycholic acid, thyroid extract, heme iron polypeptide) to regulated markets including Europe and the United States, operating under EU‑GMP and Chinese GMP certifications; in 2024 FDA issued a CGMP warning letter regarding data integrity and quality‑system deficiencies at the Sichuan Deebio Pharmaceutical API site for products exported to the U.S.[2][3][5][6].
- Therapeutic areas
- HematologyCardiovascularEndocrinologyRheumatologyGastroenterologyOphthalmology
- Modalities
- ProteinRecombinant proteinEnzymeBiologicSmall molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
Multiple global pharmaceutical clients for supply of bio‑enzyme APIs (Europe, United States, South America, India, Russia, South Korea, Japan, etc.)[2].
Beyond the preview
Go deeper on Sichuan Deebiotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sichuan Deebiotech.